Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

August 2, 2022

Study Completion Date

August 2, 2022

Conditions
Lesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/II
Interventions
DEVICE

InnoCath AB® hyper-compliant balloon catheter

endovascular treatment of lesions in the superficial femoral artery (SFA) and/or popliteal artery pars I/II without further luminal widening, and/or for short-term interruption of blood flow with the InnoCath AB® hyper-compliant balloon cathe-ters (100 or 200 mm length)

Trial Locations (2)

14129

Klinik für Diagnostische und Interventionelle Radiologie Evangelisches Krankenhaus Hubertus, Berlin

14193

Klinik für Radiologie und Nuklearmedizin Martin-Luther-Krankenhaus, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InnoRa GmbH

INDUSTRY